C4 Therapeutics, Inc.

C4 Therapeutics (Nasdaq: CCCC) is a Watertown, MA clinical-stage biopharmaceutical company developing targeted protein degradation therapies for cancer; distinct from CX Therapeutics and Cove Therapeutics.